Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Nu-Med Plus (NUMD) Equity Average (2016 - 2021)

Nu-Med Plus' Equity Average history spans 9 years, with the latest figure at -$35834.0 for Q3 2021.

  • Quarterly results put Equity Average at -$35834.0 for Q3 2021, down 111.32% from a year ago — trailing twelve months through Sep 2021 was -$35834.0 (down 111.32% YoY), and the annual figure for FY2020 was $48635.5, up 130.22%.
  • Equity Average for Q3 2021 was -$35834.0 at Nu-Med Plus, down from $94652.0 in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $344689.0 in Q4 2020 to a low of -$2.2 million in Q1 2017.
  • The 5-year median for Equity Average is -$22926.5 (2018), against an average of -$124250.2.
  • The sharpest move saw Equity Average surged 426.12% in 2018, then tumbled 1060.06% in 2019.
  • Year by year, Equity Average stood at $56608.5 in 2017, then soared by 114.64% to $121505.5 in 2018, then crashed by 377.29% to -$336922.0 in 2019, then surged by 202.31% to $344689.0 in 2020, then tumbled by 110.4% to -$35834.0 in 2021.
  • According to Business Quant data, Equity Average over the past three periods came in at -$35834.0, $94652.0, and $329329.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.